News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hospira, Inc. (HSP) Reports Fourth-Quarter and Full-Year 2012 Results


2/13/2013 6:45:18 AM

Hospira, Inc. /quotes/zigman/346012/quotes/nls/hsp HSP -1.05% , the world's leading provider of injectable drugs and infusion technologies, today reported results for the fourth quarter and full year ended Dec. 31, 2012. For the fourth quarter of 2012, net sales were $1.1 billion, and adjusted* diluted earnings per share were $0.55. (Adjusted* measures are adjusted for certain specified items as described later in this press release and the attached schedules.)

Read at Market Watch

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES